Tag:

vaksin

Health

How Long Does It Take to Recover from HMPV in Indonesia?

by Chief Editor
written by Chief Editor

Human Metapneumovirus in Indonesia: Familiar, Not New, and Not Highly Dangerous

Jakarta – A viral spotlight in China, the Human Metapneumovirus (HMPV) has been a resident of Indonesia for much longer than anticipated. All cases identified in Indonesia have involved children, but the public is urged not to panic. The virus has been known since 2001 and shares similarities with the common flu.

Minister of Health Budi Gunadi Sadikin reassured the public that HMPV is not a new virus and is not particularly deadly. However, it can lead to severe symptoms in high-risk individuals, such as children, the elderly, and those with weakened immune systems or chronic conditions like diabetes, lung diseases, or heart conditions.

HMPV: Symptoms, Transmission, and Recovery

Epidemiologist Dicky Budiman from Griffith University Australia shed light on HMPV’s transmission and recovery process. The virus spreads through coughing, sneezing, close contact, or touching surfaces contaminated by an infected person. Its incubation period ranges from three to six days.

In most cases, those infected by HMPV can recover unaided without specific treatment. Recovery typically takes between three to seven days, although this duration depends on an individual’s immunity. Currently, there’s no HMPV-specific vaccine or cure available. However, supportive care like rehydration, fever control, and rest can help alleviate symptoms.

Prevention and Protection

Pulmonary specialist Dr. Fathiyah Isbaniah emphasizes preventive measures to avoid HMPV infection. Using masks, especially when unwell, is crucial. Maintaining personal hygiene and a healthy lifestyle also plays a significant role in prevention.

"Definitely, for all viruses, it’s best to use masks. Don’t panic. If you’re sick, stay home, use a mask, and consult a doctor immediately," advises Dr. Fathiyah. "Continue practicing proper handwashing, especially if you’re not feeling well or have the flu, and use a mask or simply stay home."

Stay informed and vigilant, but remember, HMPV is not a new threat, and preventive measures we already practice can help protect us.

0 comments
0 FacebookTwitterPinterestEmail
Health

Breaking Out in China: A Comprehensive Guide to WHO’s Kata HMPV Respiratory Infection Questions

by Chief Editor
written by Chief Editor

Headline: China’s HMPV Surge: What You Need to Know About This Common Winter Virus

Subhead: As China experiences an uptick in respiratory infections, a spotlight is cast on human metapneumovirus (hMPV). Here’s what you should know about this common virus and its impact worldwide.

Article:

In the throes of winter, China has witnessed a surge in respiratory infections, drawing global attention to human metapneumovirus (hMPV), a common virus that can cause upper and lower respiratory tract illnesses in people of all ages. Data from the Chinese Center for Disease Control and Prevention (CDC) reveals an increase in cases over the past few weeks.

However, World Health Organization (WHO) spokesperson Margaret Harris assures that the reported respiratory infection rates in China remain within normal ranges for this time of year. She further notes that such trends are typical during the winter season.

"Currently, there’s no declaration of an emergency, and no emergency response has been triggered," Harris confirmed, speaking to the United Nations on January 8, 2025. "Our global influenza surveillance system has been observing an increase in influenza activity in the Northern Hemisphere, where it’s now winter, which is expected."

First identified in 2001, hMPV is not a new virus. It’s one of several that cause common colds and typically doesn’t lead to severe illness in healthy individuals. However, it can cause more serious infections in vulnerable populations, such as young children, the elderly, and those with underlying health conditions. Notably, the mortality rate of hMPV remains low.

To prevent the spread of hMPV, Harris recommends simple, hygiene-based measures: "If you have symptoms, stay home; wearing a mask in crowded places is recommended; cover your mouth and nose when coughing or sneezing; wash your hands frequently; and get the recommended vaccinations from your doctor."

In Indonesia, hMPV is also nothing new. Cases have been reported among children, with Minister of Health Budi Gunadi Sadikin confirming its presence in several laboratory data sets. However, he urges the public not to panic, as hMPV is not a novel virus like COVID-19.

"Unlike COVID-19, which emerged only a few years ago, HMPV is an old virus that has been around since 2001 and has been circulating globally since then," Minister Sadikin explained. "So far, there have been no significant issues related to it."

As winter continues, it’s essential to stay informed about common viruses like hMPV. By taking simple preventive measures and seeking medical advice when necessary, we can protect ourselves and our communities from respiratory infections.

0 comments
0 FacebookTwitterPinterestEmail
Health

Teenage Breast Growth: From Cup Size B to G Post-COVID-19 Vaccination

by Chief Editor
written by Chief Editor

Headline: Unheard-of Breast Growth After COVID-19 Vaccine Spurs Clinical Concern

Article:

In a unprecedented case, a 19-year-old woman’s breasts grew from a B-cup to a triple G size over six months following receipt of the COVID-19 vaccine. This event marks the first instance where an adverse reaction to the COVID-19 vaccine has been linked to abnormal breast growth, as reported by a team of Toronto-based researchers in the Plastic & Reconstructive Surgery-Global Open journal.

The unidentified "apparently healthy" young woman began experiencing rapid breast growth within a week of her first vaccination in September 2022, with her condition worsening after receiving her second dose. Her concerns about the vaccine’s influence on her breast size went unheeded by her primary healthcare provider, leading to a loss of trust in the healthcare system.

The study authors posited that this phenomenon, dubbed "Pfizer breasts," may be attributed to a rare condition called PASH (Plasma Cell Mastitis, Adenitis, and Sclerosing Haematoma). PASH causes benign lumps that can lead to extreme breast enlargement. The authors noted that this is the first reported case showing a temporal link between PASH and the COVID-19 vaccine.

The patient reported a sensation of numbness in her breasts prior to their growth. Blood tests revealed no hormonal changes, and prescribed steroids and antibiotics proved ineffective. Her breast growth stabilized after six months, and she underwent breast reduction surgery five months later. Unfortunately, blood loss during the procedure limited the amount of tissue that could be removed, and she remains with double D-cup breasts, potentially requiring further reduction surgery.

The Toronto-based study authors urge further investigation into a possible connection between COVID-19 vaccines, PASH, and abnormal breast growth. While breast swelling is a known side effect of COVID-19 vaccination, changes in breast structure or density are exceptionally rare.

0 comments
0 FacebookTwitterPinterestEmail
Health

H5N1 Pandemic Threat Looms: A Possible Global Crisis in 2025?

by Chief Editor
written by Chief Editor

Bird Flu H5N1: A Potential Global Health Threat by 2025

In a compelling turn of events, scientists have forecasted that bird flu, or Avian Influenza type A H5N1, could pose a serious global health threat by 2025. This virulent strain has been spreading among wild birds, cattle in several US states, and even horses in Mongolia, raising alarm bells in the health community.

The sudden surge in cases, which nearly tripled from just two instances in America over two years to a significant number in 2024, has sparked concerns. Coupled with its high fatality rate among humans, standing at an alarming 30%, the World Health Organization (WHO) has swiftly elevated its status.

Currently, H5N1 does not spread from person to person, significantly reducing pandemic risks. However, its ability to recognize and attach to specific receptors on human cells is what allows viruses to enter and replicate. While highly adapted human viruses easily recognize these receptors, H5N1, due to its bird-adaptive nature, struggles with receptor compatibility, limiting its human infection potential.

Yet, recent research has unearthed a worrying fact: a single genetic mutation could enhance H5N1’s human-to-human transmissibility. This pandemic trigger has led the global health community to strategize accordingly. Some nations, like the UK, have already procured 5 million doses of H5N1 vaccines, anticipating potential threats in 2025.

Although H5N1 still lacks human-to-human transmission capability, its impact on livestock by 2025 is predicted to be substantial. Beyond animal welfare, such an outbreak could disrupt food supplies and negatively affect the global economy.

(ASM/ HSR)

0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts